Ask AI
Managing MASH

CE / CME

Managing MASH Without Invasiveness: A Patient-Centered Approach to Early Diagnosis and Weight-Based Intervention

Physician Assistants/Physician Associates: 0.50 AAPA Category 1 CME credit

Nurse Practitioners/Nurses: 0.50 Nursing contact hour

Physicians: maximum of 0.50 AMA PRA Category 1 Credit

Released: July 14, 2025

Expiration: July 13, 2026

Pretest

Progress
1 2 3
Course Completed
Please answer the questions below.
1.

A 54-year-old man with type 2 diabetes (T2D), obesity (BMI 33 kg/m²), and well-controlled hypertension and hyperlipidemia presents with persistently elevated transaminases. Viral hepatitis panel is negative. He does not drink alcohol. Ultrasound shows hepatic steatosis.

What is the most appropriate next step in evaluation? 

2.

A 52-year-old man with T2D and obesity (BMI 34 kg/m²) is diagnosed with biopsy-confirmed MASH. Liver histology shows ballooning degeneration, lobular inflammation, and stage 2 fibrosis. He asks about lifestyle-based strategies to improve his liver disease. 

Which of the following approaches is recommended by current guidelines to assist in resolution of steatohepatitis and regression of fibrosis?